EUVIMEDEUVIMED entdecken
Open Access

Multivariate Index Assay Is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women

Charles Dunton iD, Rowan G Bullock, Herbert Fritsche

Biomarkers in Cancer · 2019

DOI: 10.1177/1179299x19853785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomarkers in Cancer, 2019. Verfasst von Charles Dunton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Lankenau Medical Center, Wynnewood, PA, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To review and analyze the serum values of risk of ovarian malignancy algorithm (ROMA) and multivariate index assay (MIA) in subgroups of women who underwent surgery for adnexal masses to determine sensitivity, specificity, and positive and negative predictive values for the detection of malignancy in different ethnic populations.

Methods

Serum samples from 2 prospective trials of 1029 women in which 274 women diagnosed with malignancy were analyzed for ROMA scores and MIA results. Biomarker data were obtained from the previous prospective studies that validated the MIA test. Of these, 250 women were Caucasian (C) and 24 were African-American (AA). Sensitivity, specificity, positive and negative predictive values, and confidence intervals for preoperative test results were calculated using DTComPair package of the R programming language. In premenopausal women, a ROMA value equal to or greater than 1.14 indicates a high risk of finding epithelial ovarian cancer. In premenopausal women, MIA values greater than 5.0 are associated with a greater risk of malignancy. In postmenopausal women, a ROMA value equal to or greater than 2.99 indicates a high risk of finding epithelial ovarian cancer. In postmenopausal women, MIA values greater than 4.4 are associated with a greater risk of malignancy.

Results

Primary ovarian malignancy was diagnosed in 179 cases (167 C/12 AA) and metastatic disease to the ovary in an additional 27 cases (22 C/5 AA). Overall results are shown below.

Conclusions

Our results demonstrate that ROMA in AA women with adnexal masses have lower sensitivity for the detection of malignancy than does MIA. Implementation of MIA in the evaluation of adnexal masses will increase the sensitivity of the detection of malignancy compared with ROMA, with the most marked results in AA women.

Schlagwörter

Stichwörter der Autor:innen

ethnicitymultivariate index assayrisk of ovarian malignancy algorithm (ROMA)

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Lankenau Medical Center, Wynnewood, PA, USA.
  • ASPiRA Labs, Vermillion, Inc, Austin, TX, USA.

ORCID-Profile: Charles Dunton

Zitieren

APA

Dunton, C., Bullock, R. G., & Fritsche, H. (2019). Multivariate Index Assay Is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women. Biomarkers in Cancer. https://doi.org/10.1177/1179299x19853785

Vancouver

Dunton C, Bullock RG, Fritsche H. Multivariate Index Assay Is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women. Biomarkers in Cancer. 2019. doi:10.1177/1179299x19853785

BibTeX
@article{Dunton2019,
  author = {Dunton, Charles and Bullock, Rowan G and Fritsche, Herbert},
  title = {Multivariate Index Assay Is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women},
  journal = {Biomarkers in Cancer},
  year = {2019},
  doi = {10.1177/1179299x19853785}
}
Kostenlos starten →